Therefore, in the current pilot study, we quantified the concentration of IL-26 in plasma samples from patients with acute COVID-19 (COVID-19 group), compared with healthy control subjects (Control group), and analyzed its association with the neutrophil-mobilizing cytokines IL-6, IL-8, and TNFα. Here, IL6 is linked to COVID-19.